StockData
Zenas BioPharma, Inc. logo

Zenas BioPharma, Inc. (ZBIO) stock

ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$27.75−0.18 (-0.64%)

Close on Nov 17, 2026Market cap $1.81BP/E –Yield –

Zenas BioPharma cash

Cash and short-term investments held at the end of each period.

Zenas BioPharma's cash was $647.10M at Sep 30, 2026. For fiscal 2025 it was $360.50M, up 2.8% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$360.50M+2.8%
FY2024Dec 31, 2024$350.80M+516.1%
FY2023Dec 31, 2023$56.94M-15.4%
FY2022Dec 31, 2022$67.30M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$647.10M+114.6%
Q2 FY2026Jun 30, 2026$673.90M+145.1%
Q1 FY2026Mar 31, 2026$718.50M+128.7%
Q4 FY2025Dec 31, 2025$360.50M+2.8%
Q3 FY2025Sep 30, 2025$301.60M-22.0%
Q2 FY2025Jun 30, 2025$274.90M+49.5%
Q1 FY2025Mar 31, 2025$314.20M+745.7%
Q4 FY2024Dec 31, 2024$350.80M+516.1%
Q3 FY2024Sep 30, 2024$386.80M+434.9%
Q2 FY2024Jun 30, 2024$183.93M+173.3%
Q1 FY2024Mar 31, 2024$37.15M–
Q4 FY2023Dec 31, 2023$56.94M–
Q3 FY2023Sep 30, 2023$72.31M–
Q4 FY2022Dec 31, 2022$67.30M–

More Zenas BioPharma figures

See a number that looks wrong?